JCR Pharmaceuticals Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JCRRF research report →
About the company
JCR Pharmaceuticals Co. , Ltd. , a specialized pharmaceutical company headquartered in Ashiya, Japan, and established in 1975, operates across the entire lifecycle of pharmaceutical products, regenerative medicines, and active drug substances.
- CEO
- Toru Ashida
- IPO
- 2021
- Employees
- 934
- HQ
- Ashiya, JP
Price Chart
- Market Cap
- $403.80M
- P/E
- 25.46
- P/S
- 1.38
- P/B
- 1.18
- EV/EBITDA
- 15.44
- Div Yield
- 4.40%
- Gross Margin
- 74.56%
- Op Margin
- 1.07%
- Net Margin
- 5.40%
- ROE
- 4.64%
- ROIC
- 0.29%
- Revenue
- $40.57B · 22.68%
- Net Income
- $2.19B · 146.08%
- EPS
- $17.58 · 145.75%
- Op Income
- $433.71M
- FCF YoY
- 24.32%
- 52W High
- $5.00
- 52W Low
- $3.15
- 50D MA
- $3.68
- 200D MA
- $4.20
- Beta
- 0.13
- Avg Volume
- 23
Get TickerSpark's AI analysis on JCRRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our JCRRF coverage
Recent articles, reports, and earnings notes.
No research on JCRRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate JCRRF report →Similar companies
Peers in the same neighborhood.